Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
Highlights CD40 expression correlates with the type I anti-tumor response and better survival. Pan-cancer bioinformatics characterization reveals reduced CD40 expression in 11 cancer types, including RAS mut melanoma compared to nevi. RAS mutation correlates with reduced CD40 expression in malignant...
Saved in:
Main Authors: | Chi Yan, Ann Richmond |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fdddad8feecb4eb2b7ceb5f48135d09a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
by: Denis I. Yudin, et al.
Published: (2021) -
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
by: Pei-Yi Chu, et al.
Published: (2021) -
Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
by: Zhao P, et al.
Published: (2021) -
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
by: Vladislav O. Sarzhevskiy, et al.
Published: (2021) -
Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis
by: Melissa L. Bastacky, et al.
Published: (2021)